Faron Pharmaceuticals Oy (AIM:FARN)
London · Delayed Price · Currency is GBP · Price in GBX 37.15
-0.85 (-2.24%)
Sep 4, 2026, 3:47 PM GMT
Faron Pharmaceuticals Oy Market Cap
Faron Pharmaceuticals Oy has a market cap or net worth of 77.09 million as of September 4, 2026. Its market cap has decreased by -66.41% in one year.
Market Cap
77.09M
Enterprise Value
64.99M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
37.15
ChartMarket Cap Chart
Since November 17, 2015, Faron Pharmaceuticals Oy's market cap has increased from 53.46M to 77.09M, an increase of 44.21%. That is a compound annual growth rate of 3.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 77.09M | -62.57% |
| Dec 31, 2025 | 205.96M | -3.97% |
| Dec 31, 2024 | 214.48M | 2.23% |
| Dec 29, 2023 | 209.80M | 16.93% |
| Dec 30, 2022 | 179.42M | 26.00% |
| Dec 31, 2021 | 142.40M | 16.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 116.37M |
| Bioventix | 90.13M |
| 4basebio | 73.81M |
| Poolbeg Pharma | 63.75M |
| Ondine Biomedical | 62.35M |
| Sareum Holdings | 48.50M |
| hVIVO | 46.72M |
| Hemogenyx Pharmaceuticals | 38.42M |